ESC Congress 2016

27 - 31 August 2016, Rome - Italy

Session Details

Hot Line heart failure and innovative approaches
Sun 28 Aug 11:00 - 12:30 Miscellaneous Hot Line Rome - Main Auditorium
Chairpersons: Mariell JESSUP (Philadelphia, United States of America), Frank RUSCHITZKA (Zurich, Switzerland)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
11:001220DANISH - A Danish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillator in patients with non-ischemic systolic heart failure on mortality)Lars KOBER (Copenhagen, Denmark)
11:101221DANISH - Discussant review.Christophe LECLERCQ (Rennes, France)
11:151222DANISH - Panel discussion. 
11:181223REM-HF - Remote monitoring: an evaluation of implantable devices for management of heart failure patientsMartin COWIE (London, United Kingdom)
11:281224REM-HF - Discussant review.Haran BURRI (Geneva, Switzerland)
11:331225REM-HF - Panel discussion. 
11:361226MORE-CARE - Effects of remote monitoring on outcomes and use of healthcare resources in heart failure patients with biventricular defibrillatorsGiuseppe BORIANI (Modena, Italy)
11:461227MORE-CARE - Discussant review. 
11:511228MORE-CARE - Panel discussion. 
11:541229CHART-1 - Phase 3 congestive heart failure cardiopoietic regenerative therapyJozef BARTUNEK (Aalst, Belgium)
12:041230CHART-1 - Discussant review.Philippe MENASCHE (Paris, France)
12:091231CHART-1 - Panel discussion. 
12:121232Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells in patients with non-ischemic cardiomyopathyJaved BUTLER (Atlanta, United States of America)
12:221233Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells in patients with non-ischemic cardiomyopathy - Discussant review. 
12:271234Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells in patients with non-ischemic cardiomyopathy - Panel discussion.